Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07031206 · ClinicalTrials.gov registry record · Phase 2
Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
NCT07031206: Clinical Trial Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
NCT07031206 is a Phase 2 study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 152 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07031206, a Phase 2 study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate pre-procedural anxiety and patient pain perception with IUD insertion/ EMB procedure when using analgesia versus no analgesia by the end of the study and to evaluate the effect of age, race, parity, type of IUD and anxiety on pain and to offer better pain management in our patient population, undergoing IUD insertion/EMB procedure at the end of our study.
Primary Outcome
VAS is scored from 1-10, higher score indicating greater pain
Interventions
- DRUG Paracervical block- Lidocaine without epinephrine
- DRUG Benzocaine Gel applied to the cervix
- DRUG Hydroxyzine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-05-05 |
| Phase | Phase 2 |
What is known before NCT07031206 opens enrollment
NCT07031206 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 3 interventions - of which Paracervical block- Lidocaine without epinephrine is the first listed.
NCT07031206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07031206 about?
NCT07031206 is a clinical study titled "Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy". The purpose of this study is to evaluate pre-procedural anxiety and patient pain perception with IUD insertion/ EMB procedure when using analgesia versus no analgesia by the end of the study and to evaluate the effect of age, race, parity, type of IUD and anxiety on pain and to offer better pain man...
What is the current status of trial NCT07031206?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2025-07-01. Estimated completion is 2026-05-05.
What interventions are being tested in trial NCT07031206?
The interventions under investigation include: Paracervical block- Lidocaine without epinephrine (DRUG), Benzocaine Gel applied to the cervix (DRUG), Hydroxyzine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT07031206?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07031206's enrollment target sits among peer trials
152 452nd of 2000 higher than 1,547 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI